News
WALTHAM, Mass., May 20, 2019 PRNewswire -- Corrona, LLC is pleased to announce a key milestone for the Corrona® Multiple Sclerosis (MS) Registry, a real-world US-based registry developed as a collaborative effort with the National MS Society. The collaborative registry model now includes Genentech...Learn More
News
Portland, Ore. (December 11, 2017) — The Corrona® Psoriasis Registry , a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC , the leading sponsor of registries in autoimmune and immune-mediated diseases, announces it has expanded into Canada and has enrolled its...Learn More
News
WALTHAM, Mass., Oct. 20, 2017 /PRNewswire/ -- Corrona, LLC and the National Multiple Sclerosis Society have announced their intent to collaborate on the launch of the Corrona Multiple Sclerosis (MS) Registry to study the comparative safety and effectiveness of approved MS therapies. The first...Learn More
News
According to results of an observational analysis, the efficacy of adalimumab is sustained in rheumatoid arthritis (RA) patients who continued therapy for 10 years. Biologic-naïve RA patients who had enrolled in the Corrona RA registry after initiating adalimumab during follow-up were included in...Learn More
News
by Ed Susman, Contributing Writer, MedPage Today ORLANDO -- Rheumatoid arthritis (RA) patients who received tocilizumab (Actemra) with methotrexate achieved low disease activity and could discontinue methotrexate while maintaining disease control, researchers said here. In a study designed to...Learn More
News
Healio Rheumatology, July 2017 With each passing year, big data has taken on a larger role in medicine and more specifically, in rheumatology. “Here is the thing about big data, it is not new. Health plans have been using big data for a long time,” Catherine MacLean, MD, PHD, from Hospital for...Learn More